Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.

[1]  R. Riffenburgh,et al.  Renal toxicity in children undergoing total body irradiation for bone marrow transplant. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  M. Budoff,et al.  Hepatitis C virus infection and the risk of coronary disease. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Tom Greene,et al.  Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate (Annals of Internal Medicine (2006) 145, (247-254)) , 2008 .

[4]  L. Verdonck,et al.  Chronic kidney disease after nonmyeloablative stem cell transplantation in adults. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  M. Sorror,et al.  Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens , 2008, Bone Marrow Transplantation.

[6]  D. Friedman,et al.  Obesity and hypertension among children after treatment for acute lymphoblastic leukemia , 2007, Cancer.

[7]  J. Sorof,et al.  Prevalence of hypertension and pre-hypertension among adolescents. , 2007, The Journal of pediatrics.

[8]  U. Berg,et al.  Long-term renal function following bone marrow transplantation , 2007, Bone Marrow Transplantation.

[9]  N. Weiss,et al.  Chronic kidney disease in long-term survivors of hematopoietic cell transplant , 2007, Bone Marrow Transplantation.

[10]  C. Lau,et al.  Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004 , 2007, Hypertension.

[11]  M. Sorror,et al.  Serious Acute or Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplantation: A Comparison of Myeloablative and Non-Myeloablative Conditioning Regimens. , 2006 .

[12]  K. Ness,et al.  Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia , 2006, Cancer.

[13]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[14]  S. Hingorani.  Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. , 2006, Journal of the American Society of Nephrology : JASN.

[15]  S. Shalitin,et al.  Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence , 2006, Bone Marrow Transplantation.

[16]  J. Wingard,et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  R. Storb,et al.  Chronic Kidney Disease Following Non‐Myeloablative Hematopoietic Cell Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  J. Steinberger,et al.  Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. , 2005, Blood.

[19]  R. Wolterbeek,et al.  Long-term renal function after hemopoietic stem cell transplantation in children , 2005, Bone Marrow Transplantation.

[20]  T. Gooley,et al.  Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia , 2004, Bone Marrow Transplantation.

[21]  B. Rosner,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .

[22]  H. Deeg,et al.  Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  M. Flowers,et al.  Diagnosis and clinical management of chronic graft-versus-host disease , 2004, International journal of hematology.

[24]  B. Storer,et al.  Diabetes Mellitus in Long-Term Survivors of Pediatric Hematopoietic Cell Transplantation , 2004, Journal of pediatric hematology/oncology.

[25]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[26]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[27]  H. Deeg,et al.  Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. , 2002, Blood.

[28]  Shumei S. Guo,et al.  2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.

[29]  S S Franklin,et al.  Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives: Analysis Based on National Health and Nutrition Examination Survey (NHANES) III , 2001, Hypertension.

[30]  U. Saarinen-Pihkala,et al.  Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood , 2000, The Lancet.

[31]  J. Fay,et al.  Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. , 2000, Blood.

[32]  S. Oparil,et al.  Essential hypertension. Part I: definition and etiology. , 2000, Circulation.

[33]  Wan Ariffin Bin Abdullah,et al.  Med Pediatr Oncol , 1999 .

[34]  R. Brand,et al.  Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT , 1998, Bone Marrow Transplantation.

[35]  E. Cohen,et al.  Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation , 1997, Bone Marrow Transplantation.

[36]  H. Deeg,et al.  Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: A prospective, randomized trial , 1997 .

[37]  M. Kumar,et al.  Kidney function in long-term pediatric survivors of acute lymphoblastic leukemia following allogeneic bone marrow transplantation. , 1996, Pediatric hematology and oncology.

[38]  K. Sullivan,et al.  Unrelated donor marrow transplantation in children. , 1995, Blood.

[39]  R. Lorini,et al.  Hyperinsulinemia in children and adolescents after bone marrow transplantation. , 1995, Bone marrow transplantation.

[40]  B. Childs,et al.  Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course. , 1994, Blood.

[41]  H. Deeg,et al.  Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. , 1994, Blood.

[42]  H. Deeg,et al.  Marrow transplant experience for children with severe aplastic anemia. , 1994, The American journal of pediatric hematology/oncology.

[43]  J. Klein,et al.  Statistical Models Based On Counting Process , 1994 .

[44]  G. McDonald,et al.  Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients , 1993, Annals of Internal Medicine.

[45]  R. Storb,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. , 1990, Blood.

[46]  H. Deeg,et al.  Graft‐versus‐host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long‐term follow‐up of a controlled trial , 1989, British journal of haematology.

[47]  R. Zager,et al.  Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  L. Brion,et al.  The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. , 1987, Pediatric clinics of North America.

[49]  J. Buring,et al.  Epidemiology in Medicine , 1987 .

[50]  R. Storb,et al.  Marrow transplantation for patients with acute lymphoblastic leukemia in remission. , 1979, Blood.

[51]  E. Cohen,et al.  RADIATION NEPHROPATHY , 1976, The Lancet.

[52]  R Storb,et al.  Bone-marrow transplantation (second of two parts). , 1975, The New England journal of medicine.

[53]  R Storb,et al.  Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.

[54]  Ross Ward,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure , 2011 .

[55]  G. Schoch,et al.  Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. , 2005, Kidney international.

[56]  E. Onusko,et al.  Diagnosing secondary hypertension. , 2003, American family physician.

[57]  G. Lönnerholm,et al.  Renal function after autologous bone marrow transplantation in children: a long-term prospective study , 2002, Bone Marrow Transplantation.

[58]  Noel R. Rose,et al.  Manual of clinical laboratory immunology , 2002 .

[59]  Paige Johnson.  Breast lumps in the adolescent female. , 2002, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[60]  R. Storb,et al.  Mini-allografts: ongoing trials in humans , 2000, Bone Marrow Transplantation.

[61]  D. Friedman,et al.  Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia. , 1999, Medical and pediatric oncology.

[62]  H. Deeg,et al.  Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial. , 1997, Blood.

[63]  C. García-Cantón,et al.  Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. , 1995, American journal of nephrology.

[64]  K. Sullivan,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. , 1990, Blood.

[65]  E. Guinan,et al.  Renal insufficiency after total body irradiation for pediatric bone marrow transplantation. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[66]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.